BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

MAIA

MAIA Biotechnology, Inc.
NYSE · Pharmaceutical preparations (SIC 2834) · FY ends 31 Dec

Revenue, quarterly

$0
$1$0
Q4 ’22
Company filings · 10-K filed 24 Mar 2023 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$0
$1$0
Q3 ’22Q3 ’23Q3 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 10 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com
Chart 05 is empty
Chart 06 is empty